Dentsply Sirona Inc. · NASDAQ:XRAY
Dentsply Sirona — Q2 2026 Earnings Presentation
16 slides from Dentsply Sirona's earnings presentation, Aug 6, 2026
Slide 1: Second Quarter 2026 Earnings Conference Call
August 6, 2026 Second Quarter 2026 Earnings Conference Call
Slide 2: Forward-Looking Statements and Associated Risks
Forward-Looking Statements and Associated Risks All statements in this Presentation that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause ac
Slide 3: Key Developments
Key Developments Delivered Q2 revenue in line with expectations Appointed seasoned finance leader John Fortson as Executive Vice President and Chief Financial Officer effective July 2026 Continued execution on Return-to-Growth Action Plan Announced new agreement with Medline Sinclair in Canada, the
Slide 4: Second Quarter 2026 Financial Summary
Second Quarter 2026 Financial Summary Commentary Q2 2026 Q2 2025 YoY ▪ Net sales (4.1%) YoY Net Sales $898M $936M (4.1%) ▪ Declines in EDS, CTS, and OIS, partially offset by Wellspect ▪ Constant currency revenue down (6.3%), Constant (6.3%) including (1.8%) impact from Byte Currency ▪ Adj. EBITDA ma
Slide 5: Second Quarter 2026 Segment Results
Second Quarter 2026 Segment Results As Constant Net Sales Commentary Reported Currency ▪ CAD/CAM: Lower volumes in Americas and unfavorable price mix in Connected EMEA, partially offset by double-digit growth in APAC Technology Solutions $239M (1.5%) (3.8%) ▪ Equipment & Instruments: Lower volumes o
Slide 6: Maintaining 2026 Outlook
Maintaining 2026 Outlook* Net Sales $3.5B to $3.6B Adjusted EPS $1.40 to $1.50 6 *Actual results may differ materially due to a number of factors and risks, including those described in the Company’s filings with the SEC Note: The benefits of refunds for tariffs are not included in the outlook for 2
Slide 7: In Summary
In Summary “ Executing on Return-to-Growth Action Plan Continuing to expand market access for Connected Technology Solutions products Advancing capital allocation strategy and sustaining improvements in working capital Reiterating outlook for net sales and adj. EPS for FY2026 7
Slide 8: Appendix
Appendix Dentsply S Sirona
Slide 9: Non-GAAP Financial Measures Definitions
Non-GAAP Financial Measures Definitions Constant Currency Adjusted Gross Profit and Margin Reported net sales adjusted for the impact of foreign currency changes, which is Gross profit excluding the impact of any of the above adjustments that affect either calculated by translating current period ne
Slide 10: Trailing Nine Quarters
Trailing Nine Quarters In millions (except percentages) Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Net Sales $984 $951 $905 $879 $936 $904 $961 $880 $898 Adjusted EBITDA $173 $170 $128 $168 $197 $167 $135 $129 $190 Adj. EBITDA Margin % 17.5% 17.9% 14.2% 19.0% 21.1% 18.4% 14.1% 14.7% 21.3%
Slide 11: Net Sales as Reported and in Constant Currency Q2 2026 and Q2 2025
Net Sales as Reported and in Constant Currency Q2 2026 and Q2 2025: (unaudited) 11
Slide 12: Reconciliation of Non-GAAP Financial Measures Q2 2026
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations Q2 2026 (unaudited) 12
Slide 13: Reconciliation of Non-GAAP Financial Measures Q2 2025
Reconciliation of Non-GAAP Financial Measures Condensed Consolidated Statements of Operations Q2 2025 (unaudited) 13
Slide 14: Reconciliation of Non-GAAP Financial Measures: Adjusted EBITDA
Reconciliation of Non-GAAP Financial Measures Adjusted EBITDA (unaudited) 14
Slide 15: Reconciliation of Non-GAAP Financial Measures: Free Cash Flow
Reconciliation of Non-GAAP Financial Measures Free Cash Flow (unaudited) 15
Slide 16: Slide 16